Kaempferol-modified mesenchymal stem cell extracellular vesicle-mimetics promote photoaging repair by suppressing ADAM10 Authors: Nan Fu, Huan Zhang, Xianhao Shi, Xian Xiao, Xiaoxia Li, Ping Song, Shihua Wang, Robert Chunhua Zhao Published: 2026 ABSTRACT AbstractChronic ultraviolet B (UVB) exposure accelerates skin photoaging by inducing excessive reactive oxygen species (ROS), inflammation, and extensive extracellular matrix (ECM) degradation. Increasing evidence indicates that extracellular vehicles (EVs) derived from mesenchymal stem cells (MSCs) hold promise for mitigating skin photoaging; however, the low yield of naturally secreted EVs poses a significant challenge to their clinical scalability. To overcome this barrier, we generated MSC-derived extracellular vesicle mimetics (MSC-EVMs), which preserved the bioactivity of EVs while enabling high-efficiency production. We further engineered a hybrid nanoplatform—MSC-EVM@Kae—by loading kaempferol (Kae), a natural inhibitor of the ECM-degrading protease ADAM10 with strong antioxidative and anti-inflammatory properties.MSC-EVM@Kae markedly reduced ROS accumulation, DNA damage, and cellular senescence in UVB-irradiated fibroblasts and keratinocytes, while restoring MMP/TIMP homeostasis through ADAM10 suppression. In a UVB-induced photoaging mouse model, microneedle-assisted transdermal delivery of MSC-EVM@Kae significantly improved wrinkle severity, enhanced collagen deposition, and reinforced epidermal barrier integrity.Collectively, our findings demonstrate that kaempferol-loaded MSC-EVM integrate the inherent regenerative potential of MSC-derived vesicles with the pharmacological inhibition of ADAM10, offering a scalable and bioengineered strategy for combating UVB-induced photoaging. This hybrid system provides a promising foundation for next-generation, cell-free therapeutics targeting skin aging and oxidative stress-related disorders.Graphical Abstract Schematic of the construction and therapeutic mechanism of EVM@Kae for UVB-induced skin photoaging. Mesenchymal stem cells (MSCs) were extruded through serial polycarbonate membranes to generate extracellular vesicle mimetics (EVM), followed by kaempferol (Kae) encapsulation. In vivo, EVM@Kae was delivered transdermally via microneedles in a UVB-induced photoaging mouse model. The treatment inhibited ADAM10 expression, reduced ROS accumulation and inflammatory cytokines (IL-1β, IL-6, TNF-α), alleviated DNA damage and SASP activation, and restored extracellular matrix integrity. Collectively, EVM@Kae effectively counteracted UVB-mediated oxidative and inflammatory injury, promoting skin regeneration and structural recovery. Supplementary InformationThe online version contains supplementary material available at 10.1186/s12964-026-02940-x.Keywords: Kaempferol, Photoaging, Mesenchymal stem cells, Extracellular vesicles, Mimetics, ADAM10 Introduction Chronic exposure to ultraviolet B (UVB) radiation is a major driver of skin photoaging, a multifactorial process characterized by oxidative stress [1], inflammatory responses [2], DNA damage [3], cellular senescence [4], and extracellular matrix (ECM) remodeling [5]. These molecular alterations collectively compromise dermal and epidermal structure, leading to wrinkles, reduced elasticity, and impaired barrier function [6, 7]. Epidermal keratinocytes and dermal fibroblasts are the primary cellular targets of UVB and play essential roles in maintaining skin homeostasis through proliferation, migration, collagen synthesis, and the secretion of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) [8–10]. Dysregulation of these processes underlies the structural and functional deterioration observed during photoaging. Multi-omics analyses have demonstrated that mesenchymal stem cell (MSC)–conditioned medium exerts notable anti-photoaging effects by attenuating cellular apoptosis and enhancing cell motility [11]. Our previous work further demonstrated that these protective effects are largely attributable to extracellular vesicles secreted by mesenchymal stem cells (MSC-EVs) [10]. Recent studies have demonstrated that engineered MSC-derived extracellular vesicles can effectively mitigate oxidative stress and protect epithelial cells from hypoxic and oxidative damage, providing a mechanistic basis for their therapeutic potential in skin-related conditions [12]. MSC-EVs have been shown to improve the cutaneous microenvironment by remodeling the extracellular matrix, enhancing fibroblast proliferation, and modulating inflammatory responses [13–15]. Despite their therapeutic promise, native MSC-EVs face substantial translational hurdles. Low secretion yield, high production cost, purification challenges and batch-to-batch heterogeneity limit their scalability and clinical feasibility [16–18]. Additionally, their complex and inherently variable molecular cargo complicates standardization and large-scale manufacturing [19, 20]. These limitations have accelerated interest in artificial or engineered EV-like systems, including exosome-mimetic nanovesicles (NVs), nanoghosts, and lipid nanoparticles (LNPs) [21, 22]. These vesicles can be fabricated in various ways, such as centrifugal filtration [23], continuous cell extrusion through membranes of different pore sizes [24], and microfluidic production [25]. In this context, extrusion-based fabrication of MSC-derived EV mimetics (MSC-EVMs) has emerged as a practical and scalable strategy. Structurally, MSC-EVMs resemble nanosized lipid-based carriers and share essential features with both natural exosomes and synthetic LNPs [22, 26]. Mechanistically, our prior findings indicate that MSC-EV exert anti-photoaging effects in part through TIMP1-dependent regulation of ADAM10, a transmembrane metalloprotease implicated in the Notch1 pathway [27]. ADAM10 regulates the cleavage of extracellular substrates and downstream signaling pathways that control MMP expression and ECM integrity, thereby contributing to collagen degradation and dermal structural deterioration [28, 29]. Given the central role of ADAM10 in mediating photoaging, targeting this protease represents a rational strategy to potentiate vesicle-based therapies. Kaempferol, a natural flavonoid, has been reported to inhibit ADAM family proteases and to exhibit potent antioxidant and anti-inflammatory activities [30, 31]. However, its poor solubility and limited transdermal penetration severely restrict topical bioavailability [31, 32]. Encapsulation within MSC-EVM may improve cellular uptake, enhance dermal retention, and preserve pharmacological activity, thereby amplifying the protective efficacy of vesicle-based therapies. Nevertheless, the stratum corneum poses a substantial barrier to vesicle delivery, often preventing nanoscale carriers from reaching therapeutically relevant skin layers and diminishing treatment efficacy [33, 34]. To overcome this obstacle, various transdermal delivery strategies have been explored, such as microneedles and hydrogels [35, 36]. Microneedles, in particular, offer minimally invasive, dosage-controlled, and depth-adjustable intradermal delivery, making them suitable for precise administration of vesicle-based therapeutics [37]. In the present study, this barrier was actively overcome by employing a microneedle-assisted transdermal delivery strategy, which enables the formation of transient microchannels across the stratum corneum and facilitates the intradermal deposition of vesicle-based formulations. Accordingly, all vesicle-based treatments, including MSC-EVM, MSC-EV, and MSC-EVM@Kae, were administered via microneedle-assisted delivery, ensuring efficient skin penetration and consistent local bioavailability. In this study, we developed kaempferol-loaded MSC-derived extracellular vesicle mimetics (EVM@Kae) and systematically evaluated their protective effects against UVB-induced photoaging. By integrating regenerative vesicle signaling with targeted inhibition of a key photoaging mediator, this work presents a bioengineered nanotherapeutic platform designed to enhance cutaneous protection and restore skin homeostasis. Results Preparation and characterization of MSC-EV and MSC-EVM Mesenchymal stem cells (MSCs) can be isolated from diverse tissue sources. In this study, human adipose-derived MSCs were employed as the primary cell source. Extracellular vesicles (MSC-EV) were isolated from conditioned culture supernatants via ultrafiltration, while the residual cells were utilized to generate MSC-derived EV-mimetics (MSC-EVM). (Figure 1 A). Preparation and characterization of MSC-EV and MSC-EVM. A Schematic diagram of the preparation process of MSC-EV and MSC-EVM. B Morphology of MSC-EV and MSC-EVM was examined by TEM (scale bar, 100 nm). C Size distribution profile of MSC-EV and MSC-EVM detected by NTA. D Western blot analysis for exosomal marker proteins HSP70, TSG101, and Alix and cell-specific marker Calnexin For structural and molecular characterization, MSC-EV and MSC-EVM were examined by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting. TEM imaging demonstrated that both MSC-EV and MSC-EVM displayed typical circular shapes with diameters ranging from 30 to 200 nm (Fig. 1B). NTA revealed a predominant particle size distribution peaking around 150 nm for both preparations (Fig. 1 C). Consistent with canonical EV characteristics, both particle types were enriched in HSP70, TSG101, and Alix. Notably, unlike MSC-EV, MSC-EVM exhibited calnexin positivity, which is consistent with their direct derivation from whole-cell extrusion rather than natural vesicle secretion (Fig. 1D). Collectively, these results indicated that MSC-EV and MSC-EVM shared comparable morphology, size distribution, and protein marker expression profiles. Given the observed potent anti-photoaging effects of MSC-EV [10] , we next sought to investigate whether MSC-EVM exhibit comparable biological activities. To this end, a series of in vitro and in vivo assays were performed to directly compare the functional efficacy of MSC-EVM with that of MSC-EV. MSC-EVM mitigate photoaging in HaCaT cells Ultraviolet B (UVB) radiation induces a cascade of photodamage events in the skin, characterized by excessive accumulation of reactive oxygen species (ROS) and extensive DNA damage, ultimately compromising genomic stability and cell viability. To assess whether MSC-EVM exert anti-photoaging effects comparable to MSC-EV, we employed human keratinocytes (HaCaTs) as an in vitro model of epidermal photoaging. We first investigated whether UVB exposure influences the uptake of MSC-EV and MSC-EVM by HaCaTs. Both vesicle types were labeled with PKH26, and fluorescence signals were compared between control and UVB-irradiated cells. No significant difference in uptake was detected, indicating that UVB irradiation does not alter the internalization of MSC-EV or MSC-EVM (Fig. 2 A). Validation and comparison of the anti-photoaging effects of MSC-EVM and MSC-EV in HaCaT. A Representative images showing the uptake of MSC-EV and MSC-EVM by HaCaT cells with or without UVB irradiation pretreatment (scale bar: 40 μm). B Representative images of SA-β-gal staining in HaCaT cells (scale bar, 50 μm). C Quantification of SA-β-gal-positive cells in HaCaT cells. D Representative images of the Transwell assay in HaCaT cells (scale bar, 100 μm). E Quantitative analysis of the Transwell assay in HaCaT cells. F Representative images of the migration assay and images captured at indicated time points (scale bar, 100 μm). G Quantification of the HaCaT cell migration assay. H Representative immunofluorescence staining images of ROS (green) and DAPI (scale bar, 20 μm) in positive cells. I Representative immunofluorescence staining images of γ-H2AX (red) and DAPI (scale bar, 20 μm). J Fluorescence intensity of ROS levels. K Quantification of the average number of γ-H2AX foci per cell. L Expression levels of Lamin B1, p53, p21, and p16 released by HaCaT cells detected by qRT-PCR. *n*= 3, ****P < 0.0001. M Western blot analysis showing changes in Lamin B1, p53, p21, and p16 in HaCaT cells. N Expression of Lamin B1, p53, p21, and p16 in HaCaT cells detected by Western blot. n = 3. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) Next, we examined the effects of MSC-EVMs on cellular photoaging phenotypes. UVB exposure markedly increased the proportion of SA-β-gal-positive HaCaTs, whereas treatment with either MSC-EVs or MSC-EVMs significantly attenuated this effect (Fig. 2B, C). Functional assays further revealed that UVB irradiation severely impaired the migratory and proliferative capacities of HaCaTs, as evidenced by Transwell (Fig. 2D, E) and scratch wound healing assays (Fig. 2 F, G). Similarly, UVB-induced ROS accumulation (Fig. 2 H, J) and γ-H2AX foci formation (Fig. 2I, K) were both substantially reduced following vesicle treatment. Notably, these impairments were significantly restored by MSC-EV or MSC-EVM treatment. At the molecular level, qRT-PCR and western blot analyses demonstrated that UVB irradiation upregulated senescence-associated markers (p53, p21, p16) and downregulated LMNB1, while stimulation with MSC-EVs or MSC-EVMs reversed these alterations (Fig. 2 L–N). Collectively, these findings indicate that UVB irradiation promotes oxidative stress, DNA damage, and cellular senescence, while suppressing epidermal cell proliferation and migration. Importantly, both MSC-EVs and MSC-EVM effectively counteract these deleterious effects, supporting the functional equivalence of MSC-EVM to MSC-EV. MSC-EVM recapitulate the anti-photoaging effects of MSC-EV in HDFs The dermis, located beneath the epidermis, constitutes the second major layer of the skin and is equally vulnerable to UVB irradiation. Dermal fibroblasts, the principal cellular components of this layer, are responsible for the synthesis of collagen and matrix metalloproteinases (MMPs), thereby regulating extracellular matrix (ECM) homeostasis and ultimately influencing skin architecture and wrinkle formation [7, 38]. To investigate the effects of UVB on the dermis, human dermal fibroblasts (HDFs)—a major source of ECM proteins-were employed. PKH26 labeling demonstrated comparable uptake of vesicles by HDFs in both control and UVB-irradiated groups, indicating that UVB exposure does not impair vesicle internalization (Fig. 3 A). Consistent with findings in keratinocytes, UVB irradiation induced pronounced cytotoxic effects in HDFs, including elevated ROS production (Fig. 3B, C), DNA damage (Fig. 3D, E), and cellular senescence (Fig. 3 F–J). Notably, treatment with either MSC-EV or MSC-EVM substantially alleviated these detrimental changes. Validation and comparison of the anti-photoaging effects of MSC-EVM and MSC-EV in HDFs. A Representative images showing the uptake of MSC-EV and MSC-EVM by HDFs with or without UVB irradiation pretreatment (scale bar, 40 μm). B Fluorescence intensity of ROS levels. C Representative immunofluorescence staining images of ROS (green) and DAPI (scale bar, 20 μm) in positive cells. D Quantification of the average number of γ-H2AX foci per cell. E Representative immunofluorescence staining images of γ-H2AX (red) and DAPI (scale bar, 20 μm) in positive cells. F Representative images of SA-β-gal staining in HDFs (scale bar, 50 μm). G Quantification of SA-β-gal-positive cells in HDFs. H Expression levels of Lamin B1, p53, p21, and p16 released by HDFs detected by qRT-PCR. I Expression levels of MMP-1, MMP-9, TIMP-1, and COL-3 released by HDFs detected by qRT-PCR. J Western blot analysis showing changes in Lamin B1, p53, p21, and p16 in HDFs. K Expression of Lamin B1, p53, p21, and p16 in HDFs detected by Western blot. L Western blot analysis showing changes in MMP-3, MMP-9, TIMP-1, and COL-3 in HDFs. M Expression of MMP-3, MMP-9, TIMP-1, and COL-3 in HDFs detected by Western blot. N Levels of IL-1β, IL-6, and TNF-α released by HDFs detected by ELISA. n = 3. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) We next assessed the impact of UVB and vesicle treatment on inflammatory responses and collagen metabolism, two processes central to dermal integrity and elasticity. Levels of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in culture supernatants were quantified by ELISA. UVB irradiation significantly elevated cytokine secretion, whereas treatment with either MSC-EV or MSC-EVM markedly attenuated these increases (Fig. 3 K), indicating effective suppression of UVB-induced inflammatory responses by both vesicle types. In parallel, UVB irradiation disrupted collagen homeostasis, as evidenced by downregulation of TIMP1 and COL3 and upregulation of MMP3 and MMP9. Vesicle treatment restored the balance of TIMP1, MMP3, MMP9, and COL3, suggesting a protective effect on ECM stability (Fig. 3 L–N). Together, these findings demonstrate that UVB irradiation induces oxidative stress, DNA damage, cellular senescence, inflammatory activation, and collagen degradation in dermal fibroblasts-hallmarks of photoaging. Importantly, both MSC-EV and MSC-EVM mitigated these alterations, thereby preserving dermal structure and function. Kaempferol exhibits anti-inflammatory, antioxidant, and anti-aging effects ADAM10, a transmembrane metalloprotease, has been shown—both in our previous work and in studies by other researchers—to contribute to UVB-induced photoaging [10, 39]. It mediates this process through the cleavage of extracellular substrates and the regulation of downstream pathways that control the expression of matrix metalloproteinases (MMPs) and compromise extracellular matrix (ECM) integrity [40, 41]. To identify a natural small-molecule inhibitor of ADAM10 for potential enhancement of MSC-EVM function, we evaluated kaempferol, a flavonoid previously reported to target ADAM family proteases in an acute kidney injury mouse model [30]. UVB irradiation significantly upregulated ADAM10 expression in both HDFs and HaCaTs, which was effectively suppressed by kaempferol treatment (Fig. 4 A, B). Consistently, kaempferol markedly reduced UVB-induced intracellular ROS accumulation (Fig. 4 C–F), alleviated cellular senescence as indicated by SA-β-galactosidase staining (Fig. 4G–I), and significantly attenuated the secretion of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, as measured by ELISA (Fig. 4 J–O), in both cell types. In vitro validation of the anti-inflammatory, antioxidant, and anti-aging effects of Kaempferol. A Representative Western blot images showing changes in ADAM10 expression in HaCaTs and HDFs after 48-hour exposure to different concentrations of Kaempferol. B Detection of ADAM10 expression in HaCaTs and HDFs by Western blot. C, D. Representative immunofluorescence staining images of ROS (green) and DAPI (blue) in HaCaTs and HDFs (scale bar, 20 μm). E, F. Fluorescence intensity of ROS levels in HaCaTs and HDFs. G. Representative images of SA-β-gal staining in HDFs and HaCaTs (scale bar, 100 μm). H, I. Quantification of SA-β-gal-positive cells in HDFs and HaCaTs. J–O. Levels of IL-1β, IL-6, and TNF-α released by HDFs and HaCaTs detected by ELISA. n = 3. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) Collectively, these results demonstrate that kaempferol effectively modulates multiple hallmarks of UVB-induced photoaging—including ADAM10 activation, oxidative stress, cellular senescence, and inflammatory responses—in both epidermal and dermal cell models. These findings provide a mechanistic rationale for incorporating kaempferol into MSC-EVM to generate a bioengineered vesicle system (MSC-EVM@Kae) with enhanced anti-photoaging potential. Preparation and characterization of EVM@Kaempferol (EVM@Kae) We successfully prepared kaempferol-loaded MSC-EVMs (EVM@Kae) using a sequential extrusion strategy (Fig. 5 A). The engineered vesicles were comprehensively characterized by TEM, NTA, and western blotting. TEM imaging revealed that EVM@Kae displayed the typical cup-shaped morphology with diameters ranging from 30 to 100 nm (Fig. 5B). Similar to unmodified EVM, EVM@Kae was enriched in canonical vesicular markers, including HSP70, TSG101, and Alix, while remaining positive for calnexin (Fig. 5 C). NTA analysis showed a peak particle size distribution of approximately 150 nm (Fig. 5D). Collectively, EVM@Kae exhibited high similarity to native EVM in morphology, particle size distribution, and marker expression. In addition, high-performance liquid chromatography (HPLC) analysis showed that the encapsulation efficiency of kaempferol in EVM was 50 ± 8% (Fig. 5E). Preparation of EVM@Kaempferol (EVM@Kae) and its in vitro validation for anti-photoaging effects. A Schematic diagram of the EVM@Kae preparation process. B Morphology of EVM@Kae observed by TEM (scale bar, 100 nm). C Western blot analysis of exosomal markers (HSP70, TSG101, Alix) and the cellular-specific marker Calnexin. D Size distribution profile of EVM and EVM@Kae detected by NTA. E Overlaid HPLC chromatograms showing the encapsulation efficiency of different concentrations of Kaempferol in EVM. n = 3. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) EVM@Kae protects HaCaT cells from UVB-induced photoaging To initially evaluate the protective effects of EVM@Kae against UVB-induced photoaging at the epidermal level, we established a UVB irradiation model in HaCaT keratinocytes and compared it with kaempferol alone, EVM, and natural EV. UVB exposure did not significantly affect the cellular uptake of EVM@Kae (Fig. 6 A). Validation of the anti-photoaging effects of EVM@Kae in HaCaT. A Representative images showing the uptake of EVM@Kae by HaCaT with or without UVB irradiation pretreatment (scale bar, 40 μm). B Representative immunofluorescence staining images of ROS (green) and DAPI (scale bar, 40 μm) in positive cells. C Fluorescence intensity of ROS levels. D Levels of IL-1β, IL-6, and TNF-α released by HaCaT detected by ELISA. E Representative images of SA-β-gal staining in HaCaT (scale bar, 100 μm). F Quantification of SA-β-gal-positive cells in HaCaT. G Expression levels of Lamin B1, p53, p21, and p16 released by HaCaT detected by qRT-PCR. H Western blot analysis showing changes in Lamin B1, p53, p21, p16, ADAM10 in HaCaT. I-J Expression of Lamin B1, p53, p21, p16, ADAM10, in HaCaT detected by Western blot. n = 3. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) UVB irradiation induced pronounced cellular damage, as evidenced by increased intracellular ROS levels, activation of inflammatory responses, and the emergence of senescence-associated phenotypes. All treatment groups alleviated these effects to varying extents. Specifically, ROS accumulation was significantly reduced (Fig. 6B, C), and pro-inflammatory cytokine expression was markedly suppressed (Fig. 6D). Notably, EVM@Kae exhibited the strongest protective effects among all groups. It more effectively reduced ROS levels and inhibited inflammatory responses compared with free kaempferol and unmodified vesicles. In addition, EVM@Kae significantly attenuated cellular senescence. SA-β-Gal staining showed a reduced proportion of senescent cells, which was confirmed by quantitative analysis (Fig. 6E, F). At the transcriptional level, EVM@Kae downregulated p53, p21, and p16 expression while partially restoring lamin B1 (Fig. 6G). These trends were further validated at the protein level by Western blot analysis and corresponding densitometric quantification (Fig. 6 H-J). In summary, EVM@Kae effectively protects HaCaT keratinocytes from UVB-induced photoaging by reducing oxidative stress, suppressing inflammation, and alleviating senescence-associated changes. EVM@Kae protects human dermal fibroblasts from UVB induced-photoaging To further validate the anti-photoaging effects of EVM@Kae at the dermal level, we next established a UVB-induced photoaging model in human dermal fibroblasts (HDFs) and compared its efficacy with kaempferol alone, EVM, and natural EV. Consistent with the observations in HaCaT cells, UVB irradiation did not significantly affect the cellular uptake of EVM@Kae (Fig. 7 A). Validation the anti-photoaging effects of EVM@Kae in HDFs. A Representative images showing the uptake of EVM@Kae by HDFs with or without UVB irradiation pretreatment (scale bar, 40 μm). B Representative images of SA-β-gal staining in HDFs (scale bar, 50 μm). C Quantification of SA-β-gal-positive cells in HDFs. D Representative immunofluorescence staining images of ROS (green) and DAPI (scale bar, 20 μm) in positive cells. E Fluorescence intensity of ROS levels. F Western blot analysis showing changes in Lamin B1, p53, p21, p16, ADAM10, MMP-3, MMP-9, TIMP-1, and COL-3 in HDFs. G Levels of IL-1β, IL-6, and TNF-α released by HDFs detected by ELISA. n = 3. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) UVB exposure induced pronounced cellular damage in HDFs, including increased senescence, elevated intracellular ROS levels, enhanced inflammatory responses, and disruption of extracellular matrix (ECM) homeostasis. All treatment groups alleviated these effects to varying degrees, as evidenced by reduced senescence (Fig. 7B–D, Supplementary Figure. 1 A, B), decreased ROS accumulation (Fig. 7E, F), suppression of inflammatory cytokine expression (Fig. 7G), and partial restoration of ECM-related markers (Supplementary Figure. 1 C, D). Notably, β-galactosidase staining and transcriptional as well as translational analyses demonstrated that EVM@Kae exerted the strongest anti-senescence effect among all groups. Furthermore, EVM@Kae showed superior anti-inflammatory activity compared with unmodified vesicles and contributed more prominently to ECM remodeling, as confirmed by both gene and protein expression profiles. In summary, we successfully engineered EVM@Kae that closely resembled native EVM in physicochemical characteristics and marker expression. Functional assays demonstrated that EVM@Kae effectively alleviated UVB-induced photoaging damage, exhibiting superior therapeutic efficacy compared with both unmodified vesicles and free kaempferol in terms of antioxidative, anti-senescence, anti-inflammatory, and ECM-regulatory activities. These findings highlight EVM@Kae as a promising bioengineered delivery platform and provide a solid experimental foundation for the development of novel therapeutics against photoaging. In vivo evaluation of EVM@Kae in UVB-induced photoaging mouse model The promising therapeutic outcomes observed in vitro prompted further investigation of the effects of EVM@Kae on skin photoaging in vivo. A UVB-induced photoaging model was established in nude mice following a standard protocol, involving UVB exposure every other day for eight weeks. Mice were randomly divided into six groups: control, UVB + PBS, UVB+kaempferol (Kae), UVB + EVM, UVB + EV, and UVB + EVM@Kae. All therapeutic formulations (PBS, Kae, EVM, EV, and EVM@Kae) were administered via microneedle-assisted-delivery, achieved by gently rolling a sterile microneedle device over the dorsal skin surface prior to topical application (Fig. 8 A). This approach was designed to enhance the percutaneous penetration and local bioavailability of the therapeutic agents. The distribution and diffusion of EVM, EV and EVM@Kae in vivo. A Schematic description of the establishment and treatment of the photoaging model (Created with BioRender.com). B Representative in vivo fluorescent imaging of PKH26-labeled EVM, EV, EVM@kae in mice at 1 h and 24 h after injection. C Biodistribution of PKH26-labeled EVM, EV, EVM@kae in mice skin at 1 h and 24 h after treatment We first evaluated the intradermal distribution and diffusion of the fluorescently labeled EVM, EV, and EVM@Kae. Immediately following administration, the fluorescent signal was uniformly distributed throughout the epidermal layer. Over 24 h, a progressive diffusion of EVM, EV, and EVM@Kae into the dermal layer was observed. No significant difference in the rate of diffusion was detected among the three formulations (Fig. 8B, C). Wrinkle formation on dorsal skin was monitored at weeks 0, 2, and 4. At baseline, few wrinkles were observed in the control group, whereas UVB-exposed mice developed prominent wrinkling, confirming successful model establishment. All treatment groups displayed varying degrees of wrinkle attenuation, potentially facilitated by microneedle-assisted delivery. Remarkably, EVM, EV, and EVM@Kae treated mice exhibited a pronounced reduction in wrinkle depth and skin thinning compared with UVB + PBS controls (Fig. 9 A). In addition, the systemic safety of the treatments was carefully evaluated. At 24 h after administration, major organs including the heart, liver, spleen, lung, and kidney were collected from the Control, EVM, EV, and EVM@Kae groups for histopathological examination. Hematoxylin and eosin(H&E) staining revealed no noticeable inflammatory cell infiltration or tissue damage in any treatment group, indicating a favorable acute safety profile (Supplementary Figure. 2 A). Furthermore, serum samples collected at the study endpoint (Day 28 after the first administration) were subjected to comprehensive biochemical analysis, including hepatic and renal function markers. No significant abnormalities were detected across the EVM-, EV-, or EVM@Kae-treated groups compared with controls. These results collectively demonstrate that microneedle-assisted transdermal administration of these vesicle-based formulations does not induce systemic toxicity in vivo (Supplementary Figure. 2B). Images of the dorsal skin in nude mice after UVB irradiation and treatment. A Representative images of mouse dorsal skin. From left to right: control group, UVB-exposed groups treated with PBS, Kae, EVM, EV and EVM@Kae. B Representative images of HE staining (scale bar, 100 μm) H&E staining revealed that UVB exposure caused marked epidermal hyperplasia and dermal thinning, both of which were substantially reversed following treatment with EVM, EV, or EVM@Kae (Fig.9B, Supplementary Figure. 2 C, D). Transepidermal water loss (TEWL), an indicator of skin barrier integrity, was significantly decreased in all treated groups relative to the UVB + PBS group (Supplementary Figure. 2E). Similarly, SA-β-gal staining and Senescence Tracker demonstrated that the UVB-induced increase in senescent cells was effectively mitigated by these treatments (Fig. 10 A-C). Collagen deposition, evaluated using Masson’s trichrome and Sirius red staining, showed a significant loss of collagen fibers in UVB-irradiated skin. Treatment with EVM, EV, or EVM@Kae restored dense, organized collagen structures, with EVM@Kae exhibiting the most pronounced recovery (Fig. 10D-F). EVG staining further confirmed the restoration of elastic fiber architecture in treated skin (Fig. 10D, G). Histological analysis of dorsal skin in nude mice after UVB irradiation and treatment. A Representative images of SA-β-gal staining (scale bar, 40 μm). B Fluorescence intensity of SA-Green levels. C Quantitation of relative β-galactosidase activity. D Representative images of Masson’s staining, picrosirius red staining and Verhoeff’s Van Gieson Staining (scale bar, 50 μm). E Quantitation of collage area from Masson’s staining statistics. F Quantitation of collage area from picrosirius red staining statistics. G Quantitation of elastin area from Verhoeff’s Van Gieson staining staining statistics. n = 6. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) Oxidative stress markers such as ROS and malondialdehyde (MDA) were significantly increased by UVB exposure but effectively reduced in the treatment groups, indicating alleviation of oxidative damage and lipid peroxidation (Fig. 11 A-C). In addition, Inflammatory cytokine profiling using a mouse cytokine array revealed that UVB irradiation elevated multiple pro-inflammatory mediators, including MIG, IL-1a, IL-1b, IL-6, IL-10, IL-33 and TNF-a. These upregulations were markedly suppressed following treatment (Fig. 11D, Supplementary Figure. 2 F-H). Finally, Immunohistochemistry (IHC) analysis revealed a marked upregulation of ADAM10 in UVB-irradiated skin, which was substantially attenuated following treatment (Fig. 11E, Supplementary Figure. 2I). This observation aligns with our in vitro findings, supporting the conclusion that EVM@Kae confers superior anti-photoaging benefits, at least in part, through the downregulation of ADAM10. Histological analysis and inflammation antibody array of the dorsal skin. A Representative immunofluorescence staining images of ROS (red) and DAPI (scale bar, 40 μm) (B) Fluorescence intensity of ROS levels. C Quantitation of MDA content. D Heatmap highlighting the representative inflammatory factors examined by the Inflammation Antibody Array. E Representative immunohistochemical (IHC) staining for ADAM-10 (scale bar, 50 μm). n = 6. Data are indicated as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, one-way analysis of variance (ANOVA) Collectively, these findings demonstrate that UVB exposure induces severe structural and biochemical alterations in skin, including inflammation, oxidative stress, and ECM disruption. Treatments with EVM, EV, or EVM@Kae effectively reversed these pathological changes, with EVM@Kae achieving the most comprehensive improvement across multiple parameters, underscoring its potential as an enhanced therapeutic strategy against photoaging. Discussion Skin photoaging is a complex biological process triggered predominantly by chronic UVB exposure, involving oxidative stress, DNA damage, inflammation, and ECM degradation [3, 42]. In this study, we demonstrate that EVM and EVM@Kae effectively mitigate these deleterious effects in both in vitro and in vivo photoaging models. Our findings provide mechanistic and translational insights into the combinatorial use of biomimetic vesicles and small-molecule modulators for anti-photoaging interventions. UVB radiation provokes excessive production of ROS, leading to oxidative DNA damage, mitochondrial dysfunction, and activation of senescence-associated pathways [43]. Concurrently, UVB upregulates ADAM10, a key protease involved in the cleavage of ECM components and activation of MMPs, thereby contributing to collagen degradation and structural deterioration of the dermis. Consistent with previous reports, we observed significant increases in ROS, γ-H2AX, and senescence markers (p53, p21, p16, and LMNB1) following UVB exposure, accompanied by disruption of MMP/TIMP homeostasis [10, 44–46]. These findings reinforce the central role of oxidative and proteolytic cascades in UVB-mediated photoaging. MSC-EV have emerged as potent mediators of tissue repair and rejuvenation via their intrinsic regenerative, anti-inflammatory, and antioxidant properties [47, 48]. Our data confirm that MSC-EV attenuate UVB-induced senescence and oxidative stress in both epidermal and dermal cells, consistent with previous studies highlighting their roles in promoting ECM repair and restoring barrier function [49]. Importantly, we show that MSC-EVM—bioengineered mimetics produced through serial extrusion—retain comparable morphology, surface markers, and functional bioactivity, while offering advantages in yield and scalability. Although their efficacy was slightly lower than that of native EV, MSC-EVM effectively reduced ROS accumulation, senescence, and inflammatory cytokine secretion, demonstrating that biomimetic vesicles can serve as a feasible alternative for large-scale therapeutic production. Kaempferol, a natural flavonoid compound with known antioxidant and anti-inflammatory properties, has been identified as a small-molecule inhibitor of ADAM family proteases [30–32]. We found that kaempferol effectively downregulated ADAM10 expression, mitigated ROS accumulation, and suppressed inflammatory cytokines (IL-1β, IL-6, and TNF-α) in both HaCaTs and HDFs following UVB exposure. Incorporation of kaempferol into MSC-EVMs via serial extrusion yielded EVM@Kae, which preserved the morphological and biochemical characteristics of native vesicles while achieving ~ 50% drug-loading efficiency. Functionally, EVM@Kae exhibited synergistic efficacy—combining vesicle-mediated regenerative signaling with pharmacological inhibition of ADAM10-driven ECM degradation. The superior performance of EVM@Kae in reducing ROS, restoring MMP/TIMP balance, and promoting collagen synthesis underscores the potential of hybrid nano-bio systems to target multiple photoaging pathways simultaneously. Importantly, these molecular changes translated into qualitatively and quantitatively improved extracellular matrix architecture, as evidenced by denser, well-organized collagen and elastin fibers in treated skin. Restoration of native skin architecture is increasingly recognized as a critical endpoint in regenerative medicine, wherein functional tissue organization—not merely biochemical marker normalization—defines true structural repair rather than transient cosmetic improvement. A recent study in complex wound models elegantly demonstrated that successful ECM remodeling correlates with re-establishment of native tissue layers and biomechanical properties, rather than simple collagen accumulation [50]. Consistent with this paradigm, our findings suggest that EVM@Kae not only enhances matrix deposition but also promotes reconstitution of the hierarchical dermal microstructure characteristic of healthy skin, thereby supporting its potential as a regenerative therapeutic strategy against photoaging. In the UVB-induced photoaging mouse model, we selected microneedle-assisted transdermal delivery as the administration route due to its minimal invasiveness, painless application, and ability to achieve precise, localized drug deposition [51]. Our results highlight the therapeutic feasibility of combining microneedle-facilitated transdermal delivery with engineered extracellular vesicles for localized and sustained skin rejuvenation. Compared with traditional topical formulations, EVM@Kae provides a biocompatible platform for the stable delivery of hydrophobic compounds such as kaempferol, minimizing degradation and enhancing tissue penetration [52, 53]. Interestingly, although kaempferol alone exhibited pronounced antioxidant and anti-inflammatory activities in vitro, its efficacy in vivo was considerably less significant. This discrepancy may be attributed to the limited dermal retention and poor bioavailability of free kaempferol following topical or transdermal administration, which restricts its ability to reach and sustain effective concentrations at target sites. In our study, encapsulation within MSC-EVMs likely prolonged the residence time of kaempferol within skin tissues, enhanced cellular uptake, and improved its local bioavailability—thereby amplifying its therapeutic effects. Nonetheless, further pharmacokinetic and biodistribution studies are required to substantiate these assumptions and to elucidate the underlying mechanisms governing the enhanced in vivo performance of EVM@Kae. Despite promising results, several limitations merit consideration. First, while EVM@Kae demonstrated enhanced efficacy relative to unmodified vesicles, the precise intracellular trafficking and biodistribution of the engineered vesicles remain to be fully elucidated. Second, the interplay between ADAM10 inhibition and other protease-mediated pathways warrants further mechanistic exploration. Additionally, long-term biosafety, immunogenicity, pharmacokinetics, and release kinetics of kaempferol from EVM@Kae following repeated transdermal application require systematic evaluation. In particular, a detailed characterization of drug release behavior under physiological skin conditions will be essential to better understand the sustained therapeutic effects observed in vivo. Future studies integrating proteomic and transcriptomic profiling may reveal broader molecular networks influenced by EVM@Kae treatment and guide further optimization of vesicle engineering and cargo selection. Conclusion Collectively, this study introduces a novel bioengineered nanoplatform—EVM@Kae—that synergistically combines the regenerative functions of stem cell-derived vesicles with the pharmacological potency of a natural ADAM10 inhibitor. By concurrently suppressing oxidative stress, inflammation, and ECM degradation, EVM@Kae provides comprehensive protection against UVB-induced photoaging. This work not only deepens mechanistic understanding of ADAM10-mediated skin aging but also establishes a versatile nanobiotechnology framework for developing next-generation, cell-free, and precision-engineered anti-aging therapeutics. Methods and materials Cell culture HDFs were purchased from the American Type Culture Collection (PCS-201-012, ATCC). HaCaTs (1101HUM-PUMC000373) were obtained from the Cell Resource Center, Peking Union Medical College (also designated as the National Science and Technology Infrastructure—National Biomedical Cell Line Resource, NSTI-BMCR). Human adipose-derived mesenchymal stem cells (MSCs) were isolated from adipose tissue donated by healthy volunteers following informed consent and subsequently cultured and expanded according to previously established protocols [54]. Adipose-derived MSCs were cultured in DMEM supplemented with 2% fetal bovine serum and 1% penicillin–streptomycin. Cells were seeded at a concentration of 7 × 103 cells/cm2 and maintained at 37 °C in a humidified atmosphere with 5% CO₂. HDFs were maintained in Fibroblast Medium (ScienCell, Cat. No. 2301). HaCaT cells were cultured in Minimum Essential Medium (MEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco), 100 U/mL penicillin (Servicebio, China), and 100 µg/mL streptomycin (Servicebio, China). MSCs were cultured in Dulbecco’s Modified Eagle Medium Nutrient Mixture F-12 (DMEM/F-12, Gibco) supplemented with 2% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin. All cells were incubated at 37 °C in a humidified atmosphere containing 5% CO₂ and subcultured using 0.25% trypsin–EDTA (Servicebio, China) upon reaching 80–90% confluence. All experimental procedures involving the collection of human adipose tissue were reviewed and approved by the Ethics Committee of the Chinese Academy of Medical Sciences and Peking Union Medical College. Isolation of MSC-EV Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) were isolated in accordance with the MISEV2018 guidelines. Briefly, when adipose-derived mesenchymal stem cells (AMSCs) reached 80–90% confluence, the culture medium was replaced with serum-free medium and the cells were incubated for an additional 48 h. The conditioned medium was subsequently collected and centrifuged at 800 × g for 5 min and 3000 × g for 10 min to remove cells and cellular debris. The supernatant was then filtered through a 0.22 μm pore-size polyethersulfone (PES) Express PLUS membrane filter (Millipore) to eliminate residual debris and larger vesicles. The filtrate was concentrated using a 100 kDa molecular weight cut-off (MWCO) centrifugal filter unit (Millipore), reducing the initial volume from approximately 250 mL to less than 5 mL. The concentrated supernatant was ultracentrifuged at 110,000 × g for 70 min at 4 °C using a Beckman Coulter ultracentrifuge. The resulting EV pellet was resuspended in phosphate-buffered saline (PBS) and subjected to a second ultracentrifugation under identical conditions (110,000 × g for 70 min, 4 °C) using a 100 Ti rotor (Beckman Coulter). The final pellet containing purified MSC-EVs was resuspended in approximately 800 µL PBS and stored at − 80 °C until further use. EVs were collected from approximately 5 × 107 MSCs per batch. EVs were prepared from multiple independent batches. For each experiment, vesicles from a single batch were used, and key experiments were repeated with independent batches to ensure reproducibility. Preparation of MSC-EVM and MSC-EVM@Kae MSC-EVMs were isolated according to a previously reported protocol [24]. Briefly, MSCs at passages 4–6 were collected and resuspended in PBS at a density of 1 × 10⁶ cells/mL. The cell suspension was sequentially extruded five times through polycarbonate membrane filters with pore sizes of 5 μm and 1 μm using a mini-extruder (Avanti Polar Lipids). The extruded material was then concentrated at 4 °C using a 100 kDa molecular weight cut-off (MWCO) membrane (Millipore), reducing the original volume of approximately 10 mL to approximately 500 µL. After ultrafiltration, the pellet was resuspended in PBS and filtered through a 0.22 μm filter to obtain purified MSC-EVMs. For the preparation of Kaempferol-loaded MSC-EVMs (MSC-EVM@Kae), the same procedure was followed, except that MSCs were initially resuspended at a density of 1 × 10⁶ cells/mL in PBS containing 20 µM Kaempferol (Sigma-Aldrich, CAS No.:520-18-3) prior to extrusion. The subsequent processing steps were identical to those described above. The resulting MSC-EVM@Kae product was obtained at a final Kaempferol concentration of approximately 10 µM. The encapsulation efficiency (EE) was calculated using the formula: EVM and EVM@Kae were prepared from multiple independent batches. For each experiment, vesicles from a single batch were used, and key experiments were repeated with independent batches to ensure reproducibility. Transmission electron microscopy (TEM) The morphology of EVs was analyzed by TEM. Freshly isolated EVs and EVMs were fixed with 1% glutaraldehyde in PBS (pH 7.4) and applied to formvar/carbon-coated grids (20 µL per grid). The grids were then negatively stained with 3% aqueous phosphotungstic acid for 5 min at room temperature in the dark. After air-drying for 10 min, the samples were observed under electron microscope (Tecnai G2 Spirit TEM, Zeiss, Oberkochen, Germany) at 120 kV. Nanoparticle tracking analysis (NTA) The particle size distribution of MSC-EV, MSC-EVM, and MSC-EVM@Kae was determined using a Zeta View nanoparticle tracking analyzer (Particle Metrix, Meerbusch, Germany) according to the manufacturer’s instructions. Samples were appropriately diluted in PBS to achieve optimal particle concentration for analysis and subsequently injected into the instrument for measurement. Induction of cell photoaging and treatment HaCaTs and HDFs were allowed to reach approximately 50% confluency and were then irradiated with UVB at a dose of 60 mJ/cm² daily using a UVB ultraviolet phototherapy device (SIGMA High-tech, Shanghai, China) for three consecutive days. Following UVB exposure, the cells were cultured in serum-free medium supplemented with the corresponding treatments for 24 h. Cells were treated with MSC-EV, MSC-EVM, and MSC-EVM@Kae at a concentration of 1 × 10¹⁰ particles/mL. Uptake assay The cellular uptake of EV, EVM and EVM@Kae was evaluated using PKH26 fluorescent labeling. Briefly, isolated EVs and EVMs were labeled with PKH26 (Sigma–Aldrich) according to the manufacturer’s instructions. To remove excess unbound dye, the labeled vesicles were subjected to ultracentrifugation, followed by repeated washing and filtration steps. Cells were seeded in 8 chambered coverglass system and cultured to approximately 70–80% confluence. Cells were then incubated with PKH26-labeled EV, EVM or EVM@Kae at a concentration of 1 × 10¹⁰ particles/mL at 37 °C. To investigate the time-dependent uptake behavior, cells were incubated with labeled vesicles and analyzed at different time points (e.g., 0.5, 2, 4 and 6 h). After incubation, cells were washed three times with PBS to remove non-internalized vesicles. Subsequently, cells were fixed with 4% paraformaldehyde for 15 min at room temperature. F-actin was stained with phalloidin (green), and nuclei were counterstained with DAPI (blue). Fluorescence images were acquired using a fluorescence microscope (Olympus, Tokyo, Japan). Mouse photoaging model and treatments Female BALB/c-nu mice were obtained from the Laboratory Animal Center of Peking Union Medical College (Beijing, China). All animal experiments were conducted in accordance with protocols approved by the Animal Care and Use Committee of the Chinese Academy of Medical Sciences (ACUC-XMSB-2025-013). The dorsal skin of nude mice was subjected to UVB irradiation (SIGMA High-tech, Shanghai, China) every other day for a total duration of 8 weeks. The minimal erythema dose (MED) was determined as 60 mJ/cm². During the first two weeks, the irradiation intensity was set at 1 MED (60 mJ/cm²). In the third week, the dose was increased to 2 MED (120 mJ/cm²), and further increased to 3 MED (180 mJ/cm²) in the fourth week. From the fifth to the eighth week, the irradiation intensity was maintained at 4 MED (240 mJ/cm²). The cumulative UVB exposure over the experimental period amounted to approximately 80 MED. Mice were randomly assigned to the following six experimental groups: (a) Control group (no UVB exposure); (b) UVB + PBS༛(c) UVB + Kaempferol (Kae)༛(d) UVB + MSC-EVM༛(e) UVB + MSC-EV༛(f) UVB + EVM@Kae. Mice in the treatment groups received dorsal microneedle-assisted injections of EVM, EV, or EVM@Kae, respectively, administered uniformly across the dorsal skin, followed by microneedle rolling. The administered dose of evsicle was 200 µg per mouse. Kaempferol (Kae) was delivered at a dose of 100 µL of a 15 µM solution per mouse. The dose of EVM@Kae (200 µg vesicle per mouse) was determined based on an entrapment efficiency of 43%, ensuring a Kaempferol equivalent dose of 0.429 µg, which is identical to the free Kaempferol group. For in vivo experiments, vesicle-based formulations (MSC-EV, MSC-EVM, and MSC-EVM@Kae) were administered at a dose of 200 µg total vesicle protein per mouse, which was used as the normalization standard for vesicle-containing treatments. Kaempferol (Kae) was administered as a free compound at a dose of 100 µL of a 15 µM solution per mouse. This dosing strategy was designed to match the administration volume and kaempferol concentration used in the preparation of MSC-EVM@Kae, thereby ensuring an equivalent amount of kaempferol delivery between the free Kae and MSC-EVM@Kae groups while allowing vesicle-based treatments to be compared on a protein-normalized basis. For in vivo transdermal administration, microneedle-assisted delivery was employed to overcome the stratum corneum barrier. Two types of commercially available microneedle devices with distinct application purposes were used in this study. A medical crystal multi-needle device with a needle length of 1.0 mm (Conpuvon, Suzhou, China) was used for localized intradermal puncture to facilitate in situ delivery. In addition, a disposable skin lancet roller with a needle length of 0.25 mm (Conpuvon, Suzhou, China) was applied by gentle rolling over the skin surface to create superficial microchannels and enhance topical permeation. After 4 weeks of treatment, the mice were euthanized, and dorsal skin samples were collected and fixed in 10% paraformaldehyde (PFA). Histological analyses, including hematoxylin and eosin (H&E) staining, Masson’s trichrome staining, and Sirius red staining, were performed on the harvested tissue sections. In vivo imaging The isolated vesicles were labeled with the fluorescent dye PKH26. Briefly, EVs were incubated with PKH26 in Diluent C at 37 °C for 10 min, after which the staining reaction was terminated by adding bovine serum albumin (BSA). Unbound dye was removed by ultracentrifugation, and the labeled vesicles were resuspended in phosphate-buffered saline (PBS). A total of 100 µL of suspension containing 200 µg of PKH26-labeled EVs was intradermally injected into the dorsal skin of nude mice. Fluorescence imaging was performed using an IVIS® imaging system (Caliper Life Sciences, Hopkinton, MA, USA) at 1 h and 24 h after injection. Mice were euthanized at these time points, and dorsal skin samples were collected and fixed in 10% paraformaldehyde (PFA). Nuclei were counterstained with DAPI (Beyotime, Shanghai, China), and images were acquired using an inverted fluorescence microscope (Olympus, Tokyo, Japan). Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. RNA concentration and purity were determined by measuring the optical density at 260/280 nm. Complementary DNA (cDNA) was synthesized from 2 µg of total RNA using the M-MLV Reverse Transcriptase Kit (Takara, Tokyo, Japan). Quantitative real-time PCR was performed using SYBR Green master mix (YESEN, Shanghai, China) on a real-time PCR detection system. The relative mRNA expression levels were calculated using the 2–ΔΔCt method and normalized to the endogenous control GAPDH. Western blotting Total protein was extracted using radioimmunoprecipitation assay (RIPA) lysis buffer supplemented with phenylmethylsulfonyl fluoride (PMSF) at a RIPA-to-PMSF ratio of 100:1. Protein concentration was quantified using a bicinchoninic acid (BCA) assay kit (Beyotime, Shanghai, China), with GAPDH serving as the internal control. Protein signals were subsequently detected using a chemiluminescence imaging system (Tanon, Shanghai, China). Total protein was extracted using radioimmunoprecipitation assay (RIPA) lysis buffer supplemented with phenylmethylsulfonyl fluoride (PMSF) at a RIPA-to-PMSF ratio of 100:1. Protein concentration was determined using a bicinchoninic acid (BCA) assay kit (Beyotime, Shanghai, China). Equal amounts of protein were separated by SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and subsequently transferred onto polyvinylidene difluoride (PVDF) membranes. The membranes were blocked with 5% non-fat milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) at room temperature and then incubated overnight at 4 °C with the indicated primary antibodies. After washing with TBST, membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies. Protein bands were visualized using an enhanced chemiluminescence (ECL) detection system and imaged with a chemiluminescence imaging system (Tanon, Shanghai, China). GAPDH was used as an internal loading control. Immunofluorescence staining Cells were fixed with 4% paraformaldehyde at room temperature for 20–30 min, followed by three washes with phosphate-buffered saline (PBS) for over 5 min each. Permeabilization was performed using 0.1% Triton X-100 at room temperature, and the cells were then washed three times with PBS (≥ 3 min per wash). Non-specific binding sites were blocked with 1% bovine serum albumin (BSA) and 0.5% Tween-20 in PBS for 60 min at room temperature. Primary antibodies were applied and incubated overnight at 4 °C. After washing with PBS, samples were incubated with corresponding secondary antibodies for 1 h at room temperature. Nuclei were counterstained with DAPI (Beyotime, Shanghai, China). Senescence-associated β-galactosidase staining Cultured cells were washed with phosphate-buffered saline (PBS), fixed with fixative solution at room temperature for 15 min, and rinsed three times with PBS. Senescence-associated β-galactosidase (SA-β-Gal) activity was detected by incubating cells in freshly prepared β-Galactosidase Staining Solution (Beyotime, Shanghai, China) at 37 °C overnight. Images were acquired using an inverted microscope (Olympus, Tokyo, Japan), and the percentage of SA-β-Gal-positive area was quantified and analyzed with ImageJ software. Skin tissue sections from nude mice were fixed with a fixation solution at room temperature for 10 min and rinsed three times with PBS. The freshly prepared SA- Green staining solution (Beyotime, Shanghai, China) was then applied to the sections and incubated at 37 °C for 30 min in the dark. After staining, the nuclei were counterstained with DAPI and mounted using an antifade mounting medium. Fluorescence images were captured using an inverted fluorescence microscope (Olympus, Tokyo, Japan), and the fluorescence intensity of SA-Green was quantitatively analyzed using ImageJ software. Reactive oxygen species (ROS) detection Intracellular reactive oxygen species (ROS) levels in HaCaT keratinocytes and human dermal fibroblasts (HDFs) were assessed using a Reactive Oxygen Species Assay Kit (Beyotime, Shanghai, China). Cells were loaded with 10 µM DCFH-DA in serum-free medium and incubated at 37 °C under 5% CO₂ for 30 min. Following incubation, the cells were washed gently with pre-warmed phosphate-buffered saline (PBS). Nuclei were counterstained with Hoechst 33,342, and fluorescence signals were visualized using a fluorescence microscope (Olympus, Tokyo, Japan). The levels of reactive oxygen species (ROS) in mouse skin tissues were assessed using a Reactive Oxygen Species Assay Kit (Beyotime, Shanghai, China). Briefly, tissue sections were incubated with 10 µM dihydroethidium (DHE) staining solution at 37 °C for 30 min. After incubation, the sections were gently washed with phosphate-buffered saline (PBS) to remove excess dye. The nuclei were counterstained with Hoechst 33,342 and mounted using an antifade mounting medium. Fluorescence signals were visualized and captured using a fluorescence microscope (Olympus, Tokyo, Japan). Transwell assay Cell migration assays were performed using 24-well Transwell chambers with 8 μm pore size filters (Corning, NY, USA). Cells were suspended in serum-free medium after 24 h of serum starvation, and 5 × 10⁴ cells were seeded into the upper chamber of each insert. The lower chamber was filled with 600 µL of medium containing 20% fetal bovine serum (FBS) as a chemoattractant. Following 12 h of incubation at 37 °C under 5% CO₂, non-migratory cells on the upper surface of the membrane were carefully removed using a cotton swab. Cells that had migrated to the lower side of the membrane were fixed and stained with 0.1% crystal violet solution. Stained cells were imaged and counted under a light microscope (Olympus, Tokyo, Japan) to quantify migration. Migration assay Cells were seeded in six-well plates and cultured at 37 °C until a confluent monolayer was formed. A uniform scratch wound was created in the monolayer using a 200 µL sterile pipette tip, followed by washing with phosphate-buffered saline (PBS) to remove detached cells. Images of the wound area in HaCaTs monolayers were captured at 0 h, 12 h, and 24 h post-scratching. The residual wound width at defined reference points was measured using ImageJ software. The migration rate was calculated as the percentage of wound closure relative to the initial wound area. Enzyme linked immunosorbent assay (ELISA) Culture media from HDFs and HaCaTs, as well as homogenates of nude mouse skin tissue, were collected and centrifuged at 3000 × g for 20 min at 4 °C. The resulting supernatant was collected, and analyte concentrations were measured using a human-specific ELISA kit (Meimian, Jiangsu, China) according to the manufacturer’s instructions. Measurement of malondialdehyde (MDA) Content Collect the homogenate of skin tissue from nude mice and centrifuge it at 8000 × g at 4℃ for 10 min. The supernatant collected was used to measure the concentration of analytes in accordance with the manufacturer’s instructions using a Malondialdehyde (MDA) Content Assay kit (Solarbio, Beijing, China). Statistical analysis Data are presented as the mean ± standard deviation (SD). All statistical analyses were performed using GraphPad Prism software (version 10.4.1). Group comparisons were analyzed by Student’s t-test, one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test, or Dunnett’s multiple comparison test. Differences were considered statistically significant at *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Supplementary Information Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Acknowledgments Supporting Information Supporting Information is available from the Wiley Online Library or from the author. Author’s contributions Author contributionsn.F. and H.Z. performed and analyzed experiments, prepared the figures, and wrote the manuscript. S.W. designed and analyzed experiments and wrote the manuscript.X.S., X.X., and X.L performed the experiments. P.S. and R.C.Z. designed the experiment. All authors have read and approved the final manuscript. Funding This project is supported by CAMS Initiative for Innovative Medicine(2022-I2M-1-012);National Natural Science Foundation of China (82474345,82471598, 82300129); This work was supported by State Key Laboratory of Common Mechanism Research of Major Diseases Platform. Data availability No datasets were generated or analysed during the current study. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Nan Fu and Huan Zhang contributed equally to this work. Contributor Information Ping Song, Email: China.songping@vip.126.com. Shihua Wang, Email: wangshihua@ibms.pumc.edu.cn. Robert Chunhua Zhao, Email: zhaochunhua@ibms.pumc.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Data Availability Statement No datasets were generated or analysed during the current study.